Pharmafile Logo

Webinar: The patient journey: Time to look beyond the physician?

March 31, 2015 | Patient journey, webinar 

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

However a recent study demonstrated that physicians spend as little as 49 seconds in dealing with a new treatment initiation with their patients.

So it is no surprise that more and more pharma marketers are steadily looking beyond the physician in order to improve patient engagement.

Pharma companies are increasingly looking at “beyond the pill” strategies in order to gain greater patient engagement and to differentiate themselves in a crowded market. And so now more than ever, the researcher needs to ensure that they have a full understanding of the patient journey in order to sufficiently support their services strategy.

In this webinar Director Katrina Johnson and Associate Director Kate Hanson explore the ways that patient journey research can aid development of an effective “beyond the pill” strategy, leading to greater patient engagement and improved treatment outcomes. 

Gain answers to your key questions:

  • Learn how to overcome pitfalls associated in marketing to a non-DTC market
  • Identify the opportunities and challenges along the journey that affect patient engagement
  • Gain a deeper understanding of how the patient journey can provide pharma with a point of differentiation in a crowded market

To view this webinar please visit http://bit.ly/1y8lj3Y

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Product launch: What market research when?

Get the insights you need, when you need them, for your product launch planning

Therapy Watch launches new tracker covering Alzheimer’s Disease

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

Therapy Watch launches new tracker covering Postpartum Depression

The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry

Infographic: Rare Diseases in China

How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.